DNA Testing Market Estimated Growth, Trends, Size, Share And Analysis 2024-2033

"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

DNA Testing Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $28.07 billion In 2028 At A CAGR Of 11.9% :

The DNA testing market size has grown rapidly in recent years. It will grow from $16.04 billion in 2023 to $17.9 billion in 2024 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to the increasing incidence of chronic diseases, rising demand for precision medicine, rising direct-to-consumer (DTC) testing, rising demand for population genomics, growing forensic investigations, and demand for genetic screening.

The DNA testing market size is expected to see rapid growth in the next few years. It will grow to $28.07 billion in 2028 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to rising incidences of genetic diseases, growing use of DNA diagnostics, growing healthcare infrastructure, growing awareness of disease prevention, rising investment by manufacturers, and increased adoption of companion diagnostics. Major trends in the forecast period include next-generation sequencing (NGS), polymerase chain reaction (PCR), preimplantation genetic diagnosis (PGD) in assisted reproductive technologies (art), miniaturization of testing devices, new DNA testing products, and development of novel assays, biomarkers, diagnostic tools, point-of-care testing, and non-invasive prenatal testing (NIPT).

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=15358&type=smp

DNA Testing Market Major Segments
The DNA testing market covered in this report is segmented -

1) By Product Type: Equipment, Consumables, Software And Services
2) By Technology: Polymerase Chain Reaction (PCR) Based, In-Situ Hybridization, Microarray, Next-Generation Sequencing (NGS) DNA Diagnosis
3) By Application: Newborn DNA Screening, Pre-natal DNA Carrier Screening, Oncology Diagnostics And Histopathology, Pre-implantation Diagnosis, Infectious Disease Diagnostics, Pharmacogenomics Diagnostic Testing, Identify Diagnostics And Forensic, Other Applications

Key Driver - Increasing Prevalence Of Genetic Disorders Fuels Growth In Genetic Testing Services Market

The increasing prevalence of genetic disorders is expected to propel the growth of the DNA testing market going forward. Genetic disorders are conditions caused by abnormalities in an individual's DNA, leading to physical or developmental abnormalities. The increasing prevalence of genetic disorders can be attributed to factors such as increased awareness, improved diagnostic techniques, expanded genetic screening, and the rising trend of consanguineous marriages in some populations. DNA testing are increasingly utilized in the diagnosis, prognosis, and treatment decision-making for individuals with genetic disorders, enabling personalized medical care and family planning strategies based on an individual's genetic makeup. For instance, in February 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, congenital diseases caused an estimated 240,000 baby deaths globally within 28 days of birth each year. Moreover, according to the Centers for Disease Control and Prevention, a US-based government agency, about 6,000 babies are born with Down syndrome in the United States each year, which is about 1 in every 700 babies. Therefore, the increasing prevalence of genetic disorders is driving the DNA testing market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=15358&type=smp

Prominent Trend - Advancements In Precancer Detection DNA Tests

Major companies operating in the DNA testing market are focused on developing advanced testing solutions such as precancer detection DNA tests, to improve the early diagnosis and treatment of cancer. Precancer detection DNA tests are diagnostic assays designed to identify genetic alterations or biomarkers associated with the early stages of cancer development. For instance, in November 2023, Lucid Diagnostics Inc., a US-based esophageal cancer prevention medical diagnostics company, launched a next-generation EsoGuard Esophageal DNA Test known as EsoGuard 2.0. This advanced esophageal DNA test utilizes molecular techniques and improved sample DNA yields to enhance assay performance and reduce costs. The test involves collecting DNA from esophageal cells using the EsoCheck Cell Collection Device, followed by bisulfite conversion, polymerase chain reaction (PCR) amplification, and next-generation sequencing to identify methylation at specific sites on genes associated with esophageal precancer and cancer. This DNA test provides results indicating the presence or absence of epigenetic changes consistent with esophageal precancer and cancer. It is an essential DNA testing tool in cancer prevention and early detection.

DNA Testing Market Players
Major companies operating in the DNA testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc, Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc, Ancestry.com LLC, 23andMe Holding Co, Ambry Genetics Corporation, MyHeritage Ltd, Biocartis SA, CENTOGENE N.V., Everlywell Inc, Atlas Biomed Group Limited, Veritas Genetics

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the DNA testing market in 2023. The regions covered in the DNA testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. DNA Testing Market Report Structure
3. DNA Testing Market Trends And Strategies
4. DNA Testing Market - Macro Economic Scenario
5. DNA Testing Market Size And Growth
…..
27. DNA Testing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.